Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M22,355Revenue (TTM) $M1,292Net Margin (%)-31.1Altman Z-Score6.2
Enterprise Value $M22,296EPS (TTM) $-1.7Operating Margin %-24.1Piotroski F-Score4
P/E(ttm)--Beneish M-Score-0.8Pre-tax Margin (%)-30.3Higher ROA y-yY
Price/Book23.310-y EBITDA Growth Rate %--Quick Ratio2.4Cash flow > EarningsY
Price/Sales16.95-y EBITDA Growth Rate %--Current Ratio2.5Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-16.8Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-42.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M247ROIC % (ttm)-48.0Gross Margin Increase y-yN

Gurus Latest Trades with VRTX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VRTXVanguard Health Care Fund 2016-03-31 Add0.5%$78.4 - $125.83
($91.01)
$ 90.38-1%Add 28.91%12,668,241
VRTXLeucadia National 2016-03-31 Buy 0.04%$78.4 - $125.83
($91.01)
$ 90.38-1%New holding3,300
VRTXJohn Paulson 2016-03-31 Add0.01%$78.4 - $125.83
($91.01)
$ 90.38-1%Add 32.54%61,500
VRTXJoel Greenblatt 2016-03-31 Reduce-0.01%$78.4 - $125.83
($91.01)
$ 90.38-1%Reduce -57.21%5,046
VRTXKen Fisher 2016-03-31 Reduce$78.4 - $125.83
($91.01)
$ 90.38-1%Reduce -7.00%5,155
VRTXVanguard Health Care Fund 2015-12-31 Add0.1%$109.03 - $133.26
($121.16)
$ 90.38-25%Add 4.34%9,827,411
VRTXJohn Paulson 2015-12-31 Buy 0.04%$109.03 - $133.26
($121.16)
$ 90.38-25%New holding46,400
VRTXJoel Greenblatt 2015-12-31 Buy 0.02%$109.03 - $133.26
($121.16)
$ 90.38-25%New holding11,793
VRTXKen Fisher 2015-12-31 Add$109.03 - $133.26
($120.93)
$ 90.38-25%Add 12.48%5,543
VRTXVanguard Health Care Fund 2015-09-30 Reduce-0.03%$98.5 - $141.48
($128.47)
$ 90.38-30%Reduce -1.21%9,418,411
VRTXKen Fisher 2015-09-30 Add$98.5 - $141.48
($128.47)
$ 90.38-30%Add 12.56%4,928
VRTXGeorge Soros 2015-06-30 Sold Out -0.07%$116.43 - $135.82
($125.88)
$ 90.38-28%Sold Out0
VRTXKen Fisher 2015-06-30 Reduce$116.43 - $135.82
($125.88)
$ 90.38-28%Reduce -0.18%4,378
VRTXVanguard Health Care Fund 2015-03-31 Reduce-0.08%$107.88 - $134.25
($119.81)
$ 90.38-25%Reduce -2.80%9,533,911
VRTXGeorge Soros 2015-03-31 Buy 0.07%$107.88 - $134.25
($119.81)
$ 90.38-25%New holding56,912
VRTXKen Fisher 2015-03-31 Add$107.88 - $134.25
($119.81)
$ 90.38-25%Add 0.18%4,386
VRTXVanguard Health Care Fund 2014-12-31 Reduce-0.58%$101.1 - $120.78
($112.61)
$ 90.38-20%Reduce -16.93%9,808,860
VRTXKen Fisher 2014-09-30 Reduce$84.74 - $113.9
($94.97)
$ 90.38-5%Reduce -31.99%4,593
VRTXVanguard Health Care Fund 2014-06-30 Add0.04%$62.44 - $94.68
($70.13)
$ 90.3829%Add 1.54%11,807,500
VRTXGeorge Soros 2014-06-30 Sold Out -0.01%$62.44 - $93.77
($69.73)
$ 90.3830%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VRTX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


VRTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BOGER JOSHUA SDirector 2016-05-25Sell5,130$89.090.99view
BOGER JOSHUA SDirector 2016-05-18Sell5,130$81.1810.83view
Sachdev AmitEVP, Policy, Access & Value 2016-05-16Sell117$81.6710.16view
Silva Paul MSVP & Corp Controller 2016-05-16Sell202$82.069.64view
SMITH IAN FEVP & CFO 2016-05-16Sell202$82.069.64view
BOGER JOSHUA SDirector 2016-05-11Sell5,130$86.54.01view
Silva Paul MSVP & Corp Controller 2016-05-09Sell3,000$87.632.67view
BOGER JOSHUA SDirector 2016-05-04Sell5,130$81.0211.05view
BOGER JOSHUA SDirector 2016-04-27Sell5,130$83.677.53view
BOGER JOSHUA SDirector 2016-04-20Sell5,130$84.16.98view

Quarterly/Annual Reports about VRTX:

    News about VRTX:

    Articles On GuruFocus.com
    Vanguard Health Care Fund Ups Stake in High-Conviction Stocks May 10 2016 
    Vanguard Boosts Stake in Incyte in 1st Quarter May 02 2016 
    Kyle Bass Sells Stakes in 11 Health Care Companies Mar 01 2016 
    Lee Ainslie Adds 90 New Stocks to His Portfolio Within the First Quarter May 20 2015 
    Analysts Confident That Vertex Pharmaceuticals' CF Drug Will Receive FDA Approval May 13 2015 
    Fate Of Cystic Fibrosis Drug By Vertex Is Now Dependent On FDA Approval May 13 2015 
    J.P. Morgan Chimes In With Ratings On BioTech Stocks Jan 06 2015 
    William Blair’s Top BioPharmaceutical Stock Picks for Q1 2015 Dec 23 2014 
    Weekly CFO Sells Highlight: Texas Instruments Inc, Royal Caribbean Cruises Ltd, Vertex Pharmaceutica Nov 09 2014 
    Weekly CFO Sells Highllight: Facebook Inc, Vertex Pharmaceuticals Inc, Nike Inc. Oct 05 2014 

    More From Other Websites
    5 Major Clinical Trial Results Coming Up May 25 2016
    Vertex Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : VRTX-US : May... May 23 2016
    [$$] French Biotech Startup Enterome Opens U.S. Offices Ahead of Fundraising May 20 2016
    Gilead Sciences: Where Do We Go From Here? May 20 2016
    Nivalis Starts Dosing in Second Phase II Cystic Fibrosis Study May 17 2016
    How Much Potential Does Vertex’s CF Pipeline Hold? May 16 2016
    Editas jumps into cystic fibrosis field with a $5M deal May 16 2016
    How Does Vertex Plan to Expand Beyond Cystic Fibrosis? May 13 2016
    Short Interest Surges In Illumina And Vertex Pharmaceuticals May 13 2016
    Cramer: How Did the Stock Market Get So Unwieldy? May 09 2016
    Vertex Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : VRTX-US : May... May 09 2016
    VERTEX PHARMACEUTICALS INC / MA Financials May 07 2016
    Inside Soliris’s Continued Growth Momentum May 04 2016
    Facebook, First Solar and Vertex are first-quarter sales winners May 04 2016
    A Promising Uptake for Vertex’s Orkambi May 04 2016
    A Look at Vertex’s Cystic Fibrosis Patient Opportunity May 04 2016
    VERTEX PHARMACEUTICALS INC / MA Files SEC form 10-Q, Quarterly Report May 03 2016
    Investing in biotech May 03 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)